Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for Manulife Financial Corporation. Read the official filing
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
John Montalbano: trading record in brief
John Montalbano discloses dealings in 2 companies, chiefly Manulife Financial Corporation and Eupraxia Pharmaceuticals Inc. In total, 6 filings cover trades dated from 15 December 2025 to 30 September 2026.
The open-market record is one-sided, with 1 purchase worth €93k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 5 share grants. In 2026 alone, the filings show 1 purchase and no sales.
The latest filing, published on 2 October 2026, reports a share grant in Manulife Financial Corporation. The last purchase on record was published on 19 August 2026, which is 59 days ago. Filings reach the SEDI feed a median of 2 days after the trade. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
Companies and markets linked to John Montalbano
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations6 total
790 sharesDeferred Share UnitsTSXSEDI:4784651
40 sharesDeferred Share UnitsTSXSEDI:4784650
22,000 shares@ CA$6.81970.020% mcap63.5% of flowCommon SharesTSXSEDI:4766116
844 sharesDeferred Share UnitsTSXSEDI:4742895
37 sharesDeferred Share UnitsTSXSEDI:4742892
10,000 shares@ CA$8.6336.5% of flowRights Restricted Stock UnitTSXSEDI:4626097
6 of 6 declarations
